{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:28:33Z","timestamp":1791088113618,"version":"4.1.0"},"reference-count":36,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2003,4,24]],"date-time":"2003-04-24T00:00:00Z","timestamp":1051142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To record prospectively, from early presentation, the clinical features of parkinsonism and tremor disorders, in relation to evidence of dopaminergic deficit shown with [\n                    <jats:sup>123<\/jats:sup>\n                    I]\u2010FP\u2010CIT (DaTSCAN, Amersham Health) single photon emission computerised tomography (SPECT). Clinical signs were recorded in 62 patients, of whom 24 failed standard Parkinson's disease (PD) and essential tremor criteria, and 38 fulfilled UK Brain Bank step 1 PD criteria. Striatal radioligand uptake was graded visually as normal or abnormal, and specific:nonspecific ratios were calculated. Bradykinesia and rigidity showed significant overall association with abnormal scans (\n                    <jats:italic>P<\/jats:italic>\n                    \u2264 0.003), but rest tremor did not (\n                    <jats:italic>P<\/jats:italic>\n                    = NS). In the 24 patients not fulfilling specific criteria (mean age 63 [SD 9] years, disease duration 3 [SD 4] years), 10 (42%) had abnormal visual SPECT assessment and 14 (58%) had normal scans. Of 38 patients with early PD by clinical criteria (mean age 60 [SD 9] years, disease duration 3 [SD 1.7] years), 33 (87%) were visually abnormal. Baseline clinical diagnosis corresponded with SPECT imaging results in 51 of 62 cases (82%), which increased to 56 of 62 cases (90%) with amendment of seven clinical diagnoses at 3 months (blind to SPECT results). Akinetic\u2013rigid cardinal diagnostic features of parkinsonism associate well with dopaminergic deficit in patients with early and mild clinical features. When these clinical features are uncertain, or the patient fails clinical diagnostic criteria, testing for dopaminergic deficit with [\n                    <jats:sup>123<\/jats:sup>\n                    I]\u2010FP\u2010CIT SPECT may assist the diagnostic process. \u00a9 2003 Movement Disorder Society\n                  <\/jats:p>","DOI":"10.1002\/mds.10482","type":"journal-article","created":{"date-parts":[[2003,9,16]],"date-time":"2003-09-16T09:36:12Z","timestamp":1063704972000},"page":"977-984","source":"Crossref","is-referenced-by-count":118,"title":["Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3\u2010month observations"],"prefix":"10.1002","volume":"18","author":[{"given":"Hani T.S.","family":"Benamer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang H.","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Pogarell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"H\u00f6ffken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gerstner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald G.","family":"Grosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,4,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.8.1497"},{"issue":"3","key":"e_1_2_5_3_2","first-page":"2","article-title":"Consensus statement of the Movement Disorder Society on tremor","volume":"3","author":"Deuschl G","year":"1998","journal-title":"Mov Disord"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.11.2184"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601113340202"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/28.2.99"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/114.5.2283"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.2.585"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.3.314"},{"issue":"4","key":"e_1_2_5_10_2","first-page":"27","article-title":"When does Parkinson's disease begin?","volume":"42","author":"Koller WC","year":"1992","journal-title":"Neurology"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360512"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890090107"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb02580.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.62.2.133"},{"key":"e_1_2_5_15_2","first-page":"1143","article-title":"Iodine\u2010123\u2010N\u2010omega\u2010fluoropropyl\u20102\u03b2\u2010carbomethoxy\u20103\u03b2\u2010(4\u2010iodophenyl)\u2010tropane SPECT in healthy controls and early stage, drug\u2010na\u00efve Parkinson's disease","volume":"37","author":"Tissingh G","year":"1998","journal-title":"J Nucl Med"},{"key":"e_1_2_5_16_2","first-page":"1760","article-title":"Comparative nigrostriatal dopaminergic imaging with iodine\u2010123\u2010\u03b2CIT\u2010FP\/SPECT and fluorine\u2010[18F]dopa\u2010PET","volume":"37","author":"Ishikawa T","year":"1996","journal-title":"J Nucl Med"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.6.1142"},{"key":"e_1_2_5_20_2","first-page":"1","volume-title":"Handbook of tremor disorders","author":"Findley LJ","year":"1994"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2007.00818.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427"},{"key":"e_1_2_5_23_2","volume-title":"Co\u2010planar stereotactic atlas of the human brain. 3\u2010dimensional proportional system: an approach to cerebral imaging","author":"Talairach J","year":"1988"},{"key":"e_1_2_5_24_2","first-page":"1263","article-title":"Apomorphine test for dopaminergic responsiveness","volume":"1","author":"Oertel WH","year":"1989","journal-title":"Lancet"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.11.1723"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1992.00530350045017"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.12968\/hosp.2001.62.8.1621"},{"key":"e_1_2_5_28_2","unstructured":"WhoneAL RemyP DavisMR et al.The REAL\u2010PET Study: slower progression in early Parkinson's disease treated with ropinirole compared withL\u2010dopa. 54th Annual Meeting of the American Academy of Neurology Denver CO 2002."},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.8.1554"},{"key":"e_1_2_5_30_2","volume-title":"Parkinson's disease and movement disorders","author":"Deuschl G","year":"1998"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130107"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.2.225"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.7.1076"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280412"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.2.167"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120203"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002590000460"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.10482","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.10482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:18:17Z","timestamp":1760962697000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.10482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,24]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1002\/mds.10482"],"URL":"https:\/\/doi.org\/10.1002\/mds.10482","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,24]]}}}